|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.031 SEK | -5.49% |
|
-20.10% | -67.37% |
The English version of the Annual Report will be available to downloaded from the company’s webpage within shortly.
For more information, please contact:
Telephone: +46 (0) 73 049 77 01
e-mail: fredrik.persson@prostatypegenomics.com
About
Prostatype® is a genetic test that is available to patients and treating urologists as a complementary decision basis for the question of treatment or non-treatment of prostate cancer. The test was developed by a research group at
© Modular Finance, source
| 1st Jan change | Capi. | |
|---|---|---|
| -67.37% | 3.01M | |
| -17.99% | 8.3B | |
| +49.55% | 3.78B | |
| -8.23% | 2.47B | |
| -34.62% | 2.46B | |
| -9.24% | 2.31B | |
| -4.14% | 1.95B | |
| -17.46% | 1.59B | |
| -37.88% | 1.21B | |
| +8.08% | 1.1B |
PROSTATYPE GENOMICS AB 